The Journal of family practice
-
A systematic review and meta-analysis says, "Yes," but that doesn't necessarily mean they will start appearing on hospital formularies.
-
Failure to control these dermatologic changes can lead to lower dosages of cancer agents or an interrupted course of Tx. These steps can help you to head off trouble.
-
This guide will help you to determine when to start an opioid taper and how to do so while maintaining pain control and minimizing the risk that the taper will fail.
-
Here's what's known about the safety of these sweeteners and their effect on weight, appetite, and the risk for type 2 diabetes.